Evidence map›Paper›PMID 35794169›Full record

ArticleScientific reports2022

Noninvasive prenatal diagnosis of genetic diseases induced by triplet repeat expansion by linked read haplotyping and Bayesian approach.

C Liautard-Haag, G Durif, C VanGoethem, D Baux, A Louis, L Cayrefourcq, M Lamairia, M Willems, C Zordan, V Dorian and 15 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03087526 (Non Invasive Prenatal Diagnosis on Isolated Circulating Fetal Trophoblastic Cells), which is not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03087526 nacompletednot on this map

Non Invasive Prenatal Diagnosis on Isolated Circulating Fetal Trophoblastic Cells (CFTC) for Triplet Repeat Diseases

TypeinterventionalSponsorUniversity Hospital, MontpellierRan2017 to 2020Enrolled60ConditionsNon Invasive Prenatal DiagnosisArmsNon invasive prenatal diagnosis
3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Non-invasive prenatal diagnosis (NIPD): current and emerging technologies.Extracellular vesicles and circulating nucleic acids · 2023
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 14 institutions in 1 country.

C Liautard-Haag *Laboratoire de Génétique Moléculaire, Institut Universitaire de Recherche Clinique, Université de Montpellier, CHU Montpellier, 641 Avenue du Doyen Gaston Giraud, 34093, Montpellier Cedex 5, France.
G Durif *IMAG, Université de Montpellier, CNRS, Montpellier, France.
C VanGoethemLaboratoire de Génétique Moléculaire, Institut Universitaire de Recherche Clinique, Université de Montpellier, CHU Montpellier, 641 Avenue du Doyen Gaston Giraud, 34093, Montpellier Cedex 5, France.
D BauxLaboratoire de Génétique Moléculaire, Institut Universitaire de Recherche Clinique, Université de Montpellier, CHU Montpellier, 641 Avenue du Doyen Gaston Giraud, 34093, Montpellier Cedex 5, France.
A LouisLaboratoire de Génétique Moléculaire, Institut Universitaire de Recherche Clinique, Université de Montpellier, CHU Montpellier, 641 Avenue du Doyen Gaston Giraud, 34093, Montpellier Cedex 5, France.
L CayrefourcqLaboratory of Rare Human Circulating Cells (LCCRH), University Medical Center of Montpellier, Montpellier, France.
M LamairiaLaboratoire de Génétique Moléculaire, Institut Universitaire de Recherche Clinique, Université de Montpellier, CHU Montpellier, 641 Avenue du Doyen Gaston Giraud, 34093, Montpellier Cedex 5, France.
M WillemsDépartement de Génétique Médicale, Maladies Rares et Médecine Personnalisée, Centre de Référence Anomalies du Développement et Syndromes Malformatifs, Université de Montpellier, CHU de Montpellier, Montpellier, France.
C ZordanService de Génétique Médicale, Groupe Hospitalier Pellegrin, CHU de Bordeaux, Bordeaux, France.
V DorianService de Génétique Médicale, Groupe Hospitalier Pellegrin, CHU de Bordeaux, Bordeaux, France.
C RooryckService de Génétique Médicale, Groupe Hospitalier Pellegrin, CHU de Bordeaux, Bordeaux, France.
C GoizetService de Génétique Médicale, Groupe Hospitalier Pellegrin, CHU de Bordeaux, Bordeaux, France.
A ChaussenotService de Génétique Médicale, Centre de Référence des Maladies Mitochondriales, Hôpital de l'Archet 2, Nice, France.
L MonteilService de Génétique Médicale, CHU de Toulouse, Toulouse, France.
P CalvasService de Génétique Médicale, CHU de Toulouse, Toulouse, France.
C MiryDepartment of Maternal Fetal Medicine, Strasbourg University Hospital, Strasbourg, France.
R FavreDepartment of Maternal Fetal Medicine, Strasbourg University Hospital, Strasbourg, France.
E Le BoetteService de Génétique Médicale, Centre Hospitalier de Saint Brieuc, Saint-Brieuc, France.
M FradinService de Génétique Médicale, Centre Hospitalier de Saint Brieuc, Saint-Brieuc, France.
A F RouxLaboratoire de Génétique Moléculaire, Institut Universitaire de Recherche Clinique, Université de Montpellier, CHU Montpellier, 641 Avenue du Doyen Gaston Giraud, 34093, Montpellier Cedex 5, France.
M CosséeLaboratoire de Génétique Moléculaire, Institut Universitaire de Recherche Clinique, Université de Montpellier, CHU Montpellier, 641 Avenue du Doyen Gaston Giraud, 34093, Montpellier Cedex 5, France.
M KoenigLaboratoire de Génétique Moléculaire, Institut Universitaire de Recherche Clinique, Université de Montpellier, CHU Montpellier, 641 Avenue du Doyen Gaston Giraud, 34093, Montpellier Cedex 5, France.
C Alix-PanabièreLaboratory of Rare Human Circulating Cells (LCCRH), University Medical Center of Montpellier, Montpellier, France.
C GuissartLaboratoire de Génétique Moléculaire, Institut Universitaire de Recherche Clinique, Université de Montpellier, CHU Montpellier, 641 Avenue du Doyen Gaston Giraud, 34093, Montpellier Cedex 5, France.
M C VincentLaboratoire de Génétique Moléculaire, Institut Universitaire de Recherche Clinique, Université de Montpellier, CHU Montpellier, 641 Avenue du Doyen Gaston Giraud, 34093, Montpellier Cedex 5, France. marie-claire.vincent@inserm.fr.
Centre Hospitalier Universitaire de Montpellier · FRHôpital Pellegrin · FRCentre Hospitalier de Saint-Brieuc · FRCentre Hospitalier Universitaire de Toulouse · FRCentre National de la Recherche Scientifique · FRInstitut Universitaire de Recherche Clinique · FRUniversité de Montpellier · FRCentre Hospitalier Universitaire de Bordeaux · FRHôpital l'Archet · FRHôpital Saint Eloi · FRHôpitaux Universitaires de Strasbourg · FRInstitut de Génétique Moléculaire de Montpellier · FRInstitute for Neurosciences of Montpellier · FRUniversité de Strasbourg · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The field of noninvasive prenatal diagnosis (NIPD) has undergone significant progress over the last decade. Direct haplotyping has been successfully applied for NIPD of few single-gene disorders. However, technical issues remain for triplet-repeat expansions. The objective of this study was to develop an NIPD approach for couples at risk of transmitting dynamic mutations. This method includes targeted enrichment for linked-read libraries and targeted maternal plasma DNA sequencing. We also developed an innovative Bayesian procedure to integrate the Hoobari fetal genotyping model for inferring the fetal haplotype and the targeted gene variant status. Our method of directly resolving parental haplotypes through targeted linked-read sequencing was smoothly performed using blood samples from families with Huntington's disease or myotonic dystrophy type 1. The Bayesian analysis of transmission of parental haplotypes allowed defining the genotype of five fetuses. The predicted variant status of four of these fetuses was in agreement with the invasive prenatal diagnosis findings. Conversely, no conclusive result was obtained for the NIPD of fragile X syndrome. Although improvements should be made to achieve clinically acceptable accuracy, our study shows that linked-read sequencing and parental haplotype phasing can be successfully used for NIPD of triplet-repeat expansion diseases.Trial registration: NCT04698551_date of first registration: 07/01/2021.

Indexed as

Noninvasive Prenatal TestingBayes TheoremFemaleHaplotypesHumansPolymorphism, Single NucleotidePregnancySequence Analysis, DNATrinucleotide Repeat Expansion

Identifiers

PMID35794169
PMCPMC9259573
OpenAlexW4283831797

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.